[Clinical characteristics of the fatal and near-fatal asthma in Alternaria alternata sensitized patients]

Med Clin (Barc). 2003 Nov 29;121(19):721-4. doi: 10.1016/s0025-7753(03)74076-7.
[Article in Spanish]

Abstract

Background and objective: Some studies have pointed to Alternaria alternata as a trigger of fatal and near-fatal asthma (NFA) crises. The objective of this study was to determine the clinical characteristics of fatal and NFA crisis in patients sensitized to Alternaria.

Patients and method: One hundred ninety four patients with fatal or NFA attacks were enrolled in a multicenter (33 Spanish hospitals), prospective study. We gathered the characteristics and clinical course of the crises. We performed the following tests: spirometry, prick-test to common allergens, and specific IgE to Alternaria when patients were in stable condition. The sensitization test to Alternaria was performed when the prick-test and/or specific IgE levels were positive.

Results: Twenty (10%) patients were sensitized to Alternaria. When compared to non-sensitized patients, Alternaria sensitized patients were significantly younger, 35 (15) vs 50 (21) years old (p<0.001); their hospital admission length was shorter, 6.5 (5.5) against 9 (7) days (p=0.039); they had a higher number of deaths or severe neurological sequelae, 15 vs 3% (p=0.026); they had a higher sensitization frequency to the remaining allergens, 68 against 22% (p=0.003); and they exhibited a fewer bronchodilation response upon inhaled salbutamol, 6 vs 10% (p=0.013).

Conclusions: The clinical characteristics of Alternaria sensitised, fatal-and NFA-patients, seem to identify a particular phenotype. Specific avoidance strategies could be useful to prevent fatal and NFA attacks.

Publication types

  • Comparative Study
  • English Abstract
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Allergens / immunology*
  • Alternaria / immunology*
  • Anti-Asthmatic Agents / therapeutic use
  • Antibodies, Fungal / blood
  • Asthma / immunology
  • Asthma / mortality*
  • Asthma / therapy
  • Child
  • Female
  • Humans
  • Immunoglobulin E / blood
  • Male
  • Middle Aged
  • Prospective Studies
  • Skin Tests
  • Spirometry

Substances

  • Allergens
  • Anti-Asthmatic Agents
  • Antibodies, Fungal
  • Immunoglobulin E